Baseline retinal testing is no longer recommended for hydroxychloroquine users in the United Kingdom

Imran H Yusuf^{1

2}, Marwan Bukhari³, James Galloway⁴, Andrew J Lotery⁵

Affiliations

¹ Nuffield Laboratory of Ophthalmology, Department of Clinical Neurosciences, Oxford University, John Radcliffe Hospital.
² Oxford Eye Hospital, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford.
³ Rheumatology Department, University Hospitals of Morecambe Bay NHS Foundation Trust, Barrow-in-Furness, Lancaster.
⁴ Centre for Rheumatic Diseases, King's College London, London.
⁵ Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.

Editorial

Imran H Yusuf et al. Rheumatology (Oxford). 2021.

. 2021 May 14;60(5):2037-2039.

doi: 10.1093/rheumatology/keab141.

Imran H Yusuf^{1

2}, Marwan Bukhari³, James Galloway⁴, Andrew J Lotery⁵

¹ Nuffield Laboratory of Ophthalmology, Department of Clinical Neurosciences, Oxford University, John Radcliffe Hospital.
² Oxford Eye Hospital, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford.
³ Rheumatology Department, University Hospitals of Morecambe Bay NHS Foundation Trust, Barrow-in-Furness, Lancaster.
⁴ Centre for Rheumatic Diseases, King's College London, London.
⁵ Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.

No abstract available

Publication types